The number one most expensive drug , as of 2020 , was Zolgensma or onasemnogene abeparvovec , a drug for the treatment of spinal muscular atrophy ( SMA ) , with a list price of around 2.13 million U.S. dollars per year . Myalept was ranked the second expensive drug , used in the long-term treatment of urea cycle disorders . Myalept is marketed by Amryt Pharma . The most costly drugs worldwide based on wholesale acquisition cost ( list price ) are mostly orphan drugs for rare diseases .
